Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B
about
Insights into Newer Antimicrobial Agents Against Gram-negative BacteriaCarbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red DotUsing an Adenosine Triphosphate Bioluminescent Assay to Determine Effective Antibiotic Combinations against Carbapenem-Resistant Gram Negative Bacteria within 24 HoursTgpA, a protein with a eukaryotic-like transglutaminase domain, plays a critical role in the viability of Pseudomonas aeruginosaFrom Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)Structural changes and differentially expressed genes in Pseudomonas aeruginosa exposed to meropenem-ciprofloxacin combination.Analysis of Pseudomonas aeruginosa cell envelope proteome by capture of surface-exposed proteins on activated magnetic nanoparticles.Novel rate-area-shape modeling approach to quantify bacterial killing and regrowth for in vitro static time-kill studies.Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosaClinical Efficacy of Polymyxin Monotherapy versus Nonvalidated Polymyxin Combination Therapy versus Validated Polymyxin Combination Therapy in Extensively Drug-Resistant Gram-Negative Bacillus Infections.Optimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling.Synergistic combinations of polymyxins.New dosing strategies for an old antibiotic: pharmacodynamics of front-loaded regimens of colistin at simulated pharmacokinetics in patients with kidney or liver disease.Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenemsCombination therapy for Gram-negative bacteria: what is the evidence?Polymyxin B versus colistin: an update.Novel Microdilution Method to Assess Double and Triple Antibiotic Combination Therapy In Vitro.Antimicrobial potentials of Helicteres isora silver nanoparticles against extensively drug-resistant (XDR) clinical isolates of Pseudomonas aeruginosa.Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa.Multidrug-resistant gram-negative bacteria infections in solid organ transplantation.Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensive Drug-resistant Pseudomonas aeruginosa.Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections.
P2860
Q26751255-605500D5-B2A3-40DD-9BD9-73DEB22976A3Q28069802-AA7A8CE9-32DF-4F7A-8B5C-FE0FBB0DD998Q28391044-D93BD359-6FE4-427D-987E-440A98CFC225Q28493237-022C9FB5-61E7-4AF8-B5FE-C42B5AB70845Q28552767-EADCDA9E-4176-4C94-AA82-59352D159BC5Q33798601-47C27AA4-22D4-4A71-A111-D467193BAF27Q34506246-CDF673B4-217F-48CF-AE57-36833A602D2AQ34922570-7FC2F58E-CA45-45C0-9A99-71C9DBAA6C61Q36887819-43CB284D-B831-44D4-AA15-DCE4F38207B9Q37023227-6E84CA04-7A51-4F7A-8062-FB78C8DAB6FBQ37538623-AC337735-ACD4-4F42-9F93-C6588029FF87Q37586960-C98AB665-860D-4A35-9390-290854E0A559Q37643631-1FCE7B9A-8046-4D51-87C8-D4AE02FF149CQ38126768-241CDD40-A2F9-4A16-A21C-EA4869C3D576Q38156194-DD395C51-0EB0-40FC-B00F-9AF7199ED52AQ38613051-F8D4E44F-E186-401C-A11F-E668EE9E5F0CQ40668393-81D27E6F-D7FE-4F58-9EA1-7B7011DC36B3Q41004268-9BAEFB05-9B47-4468-9024-A0F8DA4D675FQ41159517-6B67D8CE-BFCC-4543-AE7B-18EE0D778A5AQ42272359-CD4BD016-35EE-4932-AF4A-A2444757FCA5Q52597958-F98F60D7-52C2-4CAC-9548-35C528938C3FQ55428552-150D2D5E-2905-4C5C-832F-852C7D386AFD
P2860
Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effective antibiotics in combi ...... susceptibility to polymyxin B
@ast
Effective antibiotics in combi ...... susceptibility to polymyxin B
@en
Effective antibiotics in combi ...... susceptibility to polymyxin B
@nl
type
label
Effective antibiotics in combi ...... susceptibility to polymyxin B
@ast
Effective antibiotics in combi ...... susceptibility to polymyxin B
@en
Effective antibiotics in combi ...... susceptibility to polymyxin B
@nl
prefLabel
Effective antibiotics in combi ...... susceptibility to polymyxin B
@ast
Effective antibiotics in combi ...... susceptibility to polymyxin B
@en
Effective antibiotics in combi ...... susceptibility to polymyxin B
@nl
P2093
P2860
P3181
P1433
P1476
Effective antibiotics in combi ...... susceptibility to polymyxin B
@en
P2093
Andrea L Kwa
Jocelyn Teo
Li-Yang Hsu
Nur Syahidah
Suranthran Sasikala
Thean-Yen Tan
Thuan-Tong Tan
Tze-Peng Lim
Winnie Lee
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0028177
P407
P577
2011-01-01T00:00:00Z